US inspectors have uncovered breakdowns in drugmaking at an Indian factory owned by Sun Pharma that produces generic medications for American consumers.

Health care providers can take steps to protect patients targeted by ICE, ensuring that patients retain their privacy and access to care.

Hospital officials are warning that changes in President Donald Trump’s budget and tax bill put them on an unsustainable track that could lead to closures or loss of services in rural communities.

Prognostic Nutritional Index and systemic oxidative stress scores are associated with prognosis in patients with low-risk MDS, data suggest.

The study results “highlight how even well-intentioned efforts to save patients’ time may face barriers,” the researchers wrote.

Systematic mediastinal lymph node dissection (LND) is “unnecessary” for patients with ground glass opacity (GGO)-dominant invasive lung adenocarcinoma and low risk of nodal involvement, according to ...

The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

Resources available to clinical research physicians and the expectations placed upon these individuals vary across cancer cancers, data suggest.

Researchers recommend that details on prescription medications received in the year before diagnosis and treatment initiation be included in clinical trials as essential baseline information.

The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.